Document complet  |  Dérouler chapitre  |  Etendre sommaire  |  Version HTML imprimable
Guidelines for the Management of Sexually Transmitted Infections. February 2004
(2004; 88 pages)
Abrégé
Sexually transmitted infections (STIs) are among the most common causes of illness in the world and have far-reaching health, social and economic consequences for many countries. The emergence and spread of human immunodefi ciency virus (HIV) infection and acquired immunodefi ciency syndrome (AIDS) have had a major impact on the management and control of STIs. At the same time, resistance of several sexually transmitted pathogens to antimicrobial agents has increased, adding to therapeutic problems. In 1991, WHO published recommendations for the comprehensive management of patients with STIs within the broader context of control, prevention and care programmes for STI and HIV infection. WHO convened an Advisory Group Meeting on Sexually Transmitted Diseases Treatment in May 1999 to review and update treatment recommendations in the light of recent developments (see Annex 1). In November 2001, an expert consultation on improving the management of STIs was convened by WHO in Geneva (see Annex 2). The consultation focused on the syndromes of genital ulcers and vaginal discharge. The former because of the observed increase of herpes simplex virus type 2 (HSV2) as the main cause of genital ulcers in developing countries, and the latter for its continued complexity and controversy as an entry point for managing cervical gonococcal and chlamydial infections. Recommendations from the consultation have led to the revisions included in this publication, covering the two areas of syndromic management of genital ulcer disease and vaginal discharge.
Table des matières
Afficher le documentPREFACE
Ouvrir ce répertoire et afficher son contenu1. INTRODUCTION
Ouvrir ce répertoire et afficher son contenu2. TREATMENT OF STI-ASSOCIATED SYNDROMES
Ouvrir ce répertoire et afficher son contenu3. TREATMENT OF SPECIFIC INFECTIONS
Ouvrir ce répertoire et afficher son contenu4. KEY CONSIDERATIONS UNDERLYING TREATMENTS
Ouvrir ce répertoire et afficher son contenu5. PRACTICAL CONSIDERATIONS IN STI CASE MANAGEMENT
Ouvrir ce répertoire et afficher son contenu6. CHILDREN6, ADOLESCENTS AND SEXUALLY TRANSMITTED INFECTIONS
Afficher le documentANNEX. LIST OF PARTICIPANTS
 

Guidelines for the Management of Sexually Transmitted Infections. February 2004

World Health Organization

WHO/HIV_AIDS/2001.01
WHO/RHR/01.10
Original: English
Distr.: General

Copyright © World Health Organization 2001.

This document is not a formal publication of the World Health Organisation (WHO), and all rights are reserved by the Organisation.

The document may, however, be freely reviewed, abstracted, reproduced or translated, in part or in whole, but not for sale or for use in conjunction with commercial purposes.

The views expressed in documents by named authors are solely the responsibility of those authors.

Design by RSdeSigns.com.

Note 1999

The World Health Organization recommends that the term sexually transmitted disease (STD) be replaced by the term sexually transmitted infections (STI). The term sexually transmitted infections has been adopted as it better incorporates asymptomatic infections. In addition, the term has been adopted by a wide range of scientific and publications.

Reproductive tract infections encompass three main groups of infection, particularly in women, and sometimes in men. These groups are endogenous infections in the female genital tract (e.g. candidiasis and bacterial vaginosis), iatrogenic infections that may be acquired through non-sterile medical, personal or cultural practices and classical STI. Currently, research in being conducted to better understand the determinants of endogenous infections. They are not primarily sexually transmitted; thus, clinical and public health actions as recommended for STI may not apply to these infections. Given the current state of knowledge and understanding of these infections treatment of partners is not recommended as routine public health practice. Reassurance and patient education are critical with regard to the nature of these endogenous infections.

 

vers la section suivante
 
 
Le Portail d'information - Médicaments essentiels et produits de santé a été conçu et est maintenu par l'ONG Human Info. Dernière mise à jour: le 1 décembre 2019